What is the role of interleukin 33 and ST2 receptor in myasthenia gravis?

Volume: 315, Pages: 50 - 57
Published: Feb 1, 2018
Abstract
Myasthenia gravis (MG) is a disease with autoimmune etiology. The main pathomechanism is related to the production of antibodies against nicotinic acetylcholine receptor (AChR) located in the postsynaptic membrane. The present study is set to compare the serum level of interleukin-33 (IL-33)/receptor ST2 in patients with myasthenia gravis and controls; and to study the relation with the severity of disease. Our observations confirm that a...
Paper Details
Title
What is the role of interleukin 33 and ST2 receptor in myasthenia gravis?
Published Date
Feb 1, 2018
Volume
315
Pages
50 - 57
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.